Related Experiment Video
Updated: Mar 2, 2026

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity,
Hilaire C Lam1, Christian V Baglini1, Alicia Llorente Lope1
1Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Abstract:
p62/sequestosome-1 (SQSTM1) is a multifunctional adaptor protein and autophagic substrate that accumulates in cells with hyperactive mTORC1, such as kidney cells with mutations in the tumor suppressor genes tuberous sclerosis complex (TSC)1 or TSC2. Here we report that p62 is a critical mediator of TSC2-driven tumorigenesis, as Tsc2+/- and Tsc2f/f Ksp-CreERT2+ mice crossed to p62-/- mice were protected from renal tumor development. Metabolic profiling revealed that depletion of p62 in Tsc2-null cells decreased intracellular glutamine, glutamate, and glutathione (GSH). p62 positively regulated the glutamine transporter Slc1a5 and increased glutamine uptake in Tsc2-null cells. We also observed p62-dependent changes in Gcl, Gsr, Nqo1, and Srxn1, which were decreased by p62 attenuation and implicated in GSH production and utilization. p62 attenuation altered mitochondrial morphology, reduced mitochondrial membrane polarization and maximal respiration, and increased mitochondrial reactive oxygen species and mitophagy marker PINK1. These mitochondrial phenotypes were rescued by addition of exogenous GSH and overexpression of Sod2, which suppressed indices of mitochondrial damage and promoted growth of Tsc2-null cells. Finally, p62 depletion sensitized Tsc2-null cells to both oxidative stress and direct inhibition of GSH biosynthesis by buthionine sulfoximine. Our findings show how p62 helps maintain intracellular pools of GSH needed to limit mitochondrial dysfunction in tumor cells with elevated mTORC1, highlighting p62 and redox homeostasis as nodal vulnerabilities for therapeutic targeting in these tumors. Cancer Res; 77(12); 3255-67. ©2017 AACR.
Insights
p62 protein is crucial for kidney tumor development in TSC2-deficient cells by maintaining glutathione levels and mitochondrial function. Its depletion protects against tumor growth and sensitizes cells to oxidative stress.
Area of Science:
- Oncology
- Cell Biology
- Metabolism
Background:
- p62/sequestosome-1 (SQSTM1) accumulates in cells with hyperactive mTORC1, common in kidney tumors with tuberous sclerosis complex (TSC) gene mutations.
- p62 is an autophagic substrate and adaptor protein with a role in cellular signaling and stress response.
Purpose of the Study:
- To investigate the role of p62 in TSC2-deficient renal tumorigenesis.
- To elucidate the mechanisms by which p62 influences cellular metabolism and mitochondrial function in the context of TSC2 loss.
Main Methods:
- Utilized genetically modified mouse models (Tsc2+/-, Tsc2f/f Ksp-CreERT2+ crossed with p62-/-).
- Performed metabolic profiling, gene expression analysis, and mitochondrial function assays.
- Assessed cellular responses to oxidative stress and glutathione biosynthesis inhibition.
Main Results:
- p62 deficiency protected mice from TSC2-driven renal tumor development.
- p62 depletion reduced intracellular glutamine, glutamate, and glutathione (GSH) by downregulating the glutamine transporter Slc1a5.
- p62 attenuation impaired mitochondrial morphology, reduced membrane potential and respiration, and increased reactive oxygen species, effects rescued by GSH or Sod2.
- p62-depleted Tsc2-null cells showed increased sensitivity to oxidative stress and GSH biosynthesis inhibition.
Conclusions:
- p62 is a critical mediator of TSC2-driven renal tumorigenesis.
- p62 maintains intracellular GSH pools, limiting mitochondrial dysfunction in mTORC1-hyperactive tumor cells.
- p62 and redox homeostasis represent potential therapeutic targets for these tumors.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Mitogens and the Cell Cycle

